Patents expiring in 2034

US 8901277

Interferon alpha mutant and its polyethylene glycol derivative

Beijing Tri-Prime Genetic Engineering Co., Ltd · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901276

Peptide reagents and methods for detection of colon dysplasia

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901246

Method for preparing branched functionalized polymers using branched polyol cores

Nektar Therapeutics · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901199

Compositions and methods for UV-curable cosmetic nail coatings

Creative Nail Design Inc. · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901173

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

Jazz Pharmaceuticals, Inc. · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8901117

Small molecule inhibitors of MDM2 and the uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8900599

Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2014356438

PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS

ALLERGAN INC [US] · Granted Thu Dec 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2014357564

Von Willebrand Factor Variants Having Improved Factor VIII Binding Affinity

CSL BEHRING GMBH [DE] · Granted Thu Dec 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906939

3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives

Addex Pharma, S.A. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8907053

Immunosuppression modulating compounds

Aurigene Discovery Technologies Limited · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906870

MicroRNA (miRNA) for the diagnosis and treatment of heart diseases

Julius-Maximilians-Universitat Wurzburg · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8905913

Method and composition for synchronizing time of insemination

JBS United Animal Health II LLC · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906151

Calcium phosphate composition and process for producing the same

KURARAY NORITAKE DENTAL INC. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906353

Compositions and methods for achieving sustained therapeutic drug concentrations in a subject

Nektar Therapeutics · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906358

Leishmania challenge model

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906384

Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906411

Pre-compacted calcium-containing compositions

TAKEDA NYCOMED AS · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906668

Synergistic bacterial compositions and methods of production and use thereof

Seres Health, Inc. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906853

[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906863

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

The Regents of the University of California · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906897

Antimicrobial agents based on hemin derivatives

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906901

Administration of dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906922

Substituted triazoles useful as AXl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906949

Orally disintegrating tablets of zolmitriptan and process for preparing the same

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906964

Methods of administering compositions comprising docosapentaenoic acid

MATINAS BIOPHARMA INC. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8907089

Fused heterocyclic ring derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906343

PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906413

Drug formulations having reduced abuse potential

Supernus Pharmaceuticals, Inc. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906862

Multiple antigen delivery system using hepatitis E virus-like particle

The Regents of the University of California · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906872

Antisense antiviral compound and method for treating ssRNA viral infection

Sarepta Therapeutics, Inc. · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8906917

Pyrimidine cyclohexyl glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8907060

Mutated Pseudomonas exotoxins with reduced antigenicity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8905235

Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom

Nektar Therapeutics · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2853911

PROCEDE DE FABRICATION DE MELANGES GAZEUX NO/N2 DESTINES AU DOMAINE MEDICAL

AIR LIQUIDE SANTE INT [FR] · Granted Fri Dec 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8911733

Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8911729

Stem cell factor inhibitor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8911743

Haemophilus parasuis polypeptides and methods of use

Regents of the University of Minnesota · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912170

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912172

Skin external preparation containing triterpenic acid

KURARAY CO., LTD. · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912138

DNA-binding proteins and uses thereof

Sangamo Biosciences, Inc. · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912142

Method of regulating proliferation and differentiation of keratinocyes

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912323

Multifunctional small molecules

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8911742

Transcutaneous immunization without heterologous adjuvant

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912334

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912198

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8912185

Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)